Exchange Capital Management, Inc. Pfizer Inc Transaction History

Exchange Capital Management, Inc.

$593 Million
Q3 2024

A detailed history of Exchange Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Exchange Capital Management, Inc. holds 33,803 shares of PFE stock, worth $903,216. This represents 0.16% of its overall portfolio holdings.

Number of Shares

33,803

Previous 34,533 2.11%

Holding current value

$903,216

Previous $966,000 1.24%

% of portfolio

0.16%

Previous 0.16%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$27.7 - $31.39 $20,221 - $22,914	-730 Reduced 2.11%	33,803 $978,000
Q2 2024 Jul 23, 2024	SELL	$25.26 - $29.6 $13,008 - $15,244	-515 Reduced 1.47%	34,533 $966,000
Q1 2024 Apr 18, 2024	BUY	$25.89 - $29.73 $12,945 - $14,865	500 Added 1.45%	35,048 $972,000
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $944,050 - $1.23 Million	-36,129 Reduced 51.12%	34,548 $994,000
Q3 2023 Oct 30, 2023	SELL	$32.09 - $37.51 $111,416 - $130,234	-3,472 Reduced 4.68%	70,677 $2.34 Million
Q2 2023 Jul 24, 2023	SELL	$36.12 - $41.79 $94,020 - $108,779	-2,603 Reduced 3.39%	74,149 $2.72 Million
Q1 2023 May 03, 2023	BUY	$39.39 - $51.28 $26,942 - $35,075	684 Added 0.9%	76,752 $3.13 Million
Q4 2022 Jan 31, 2023	SELL	$41.75 - $54.5 $229,207 - $299,205	-5,490 Reduced 6.73%	76,068 $3.9 Million
Q3 2022 Oct 31, 2022	SELL	$43.76 - $53.42 $304,394 - $371,589	-6,956 Reduced 7.86%	81,558 $3.57 Million
Q2 2022 Jul 28, 2022	SELL	$46.53 - $55.17 $145,499 - $172,516	-3,127 Reduced 3.41%	88,514 $4.64 Million
Q1 2022 Apr 28, 2022	SELL	$45.75 - $56.69 $139,446 - $172,791	-3,048 Reduced 3.22%	91,641 $4.74 Million
Q4 2021 Jan 27, 2022	SELL	$41.32 - $61.25 $70,202 - $104,063	-1,699 Reduced 1.76%	94,689 $5.59 Million
Q3 2021 Nov 01, 2021	SELL	$39.25 - $50.42 $113,354 - $145,612	-2,888 Reduced 2.91%	96,388 $4.15 Million
Q2 2021 Aug 05, 2021	BUY	$35.91 - $40.68 $6,356 - $7,200	177 Added 0.18%	99,276 $3.89 Million
Q1 2021 May 10, 2021	BUY	$33.49 - $37.77 $304,625 - $343,555	9,096 Added 10.11%	99,099 $3.59 Million
Q4 2020 Feb 05, 2021	BUY	$33.47 - $42.56 $205,940 - $261,871	6,153 Added 7.34%	90,003 $3.31 Million
Q3 2020 Nov 06, 2020	BUY	$31.75 - $37.25 $101,123 - $118,641	3,185 Added 3.95%	83,850 $3.08 Million
Q2 2020 Aug 04, 2020	SELL	$30.12 - $36.54 $9,789 - $11,875	-325 Reduced 0.4%	80,665 $2.64 Million
Q1 2020 Apr 28, 2020	BUY	$27.03 - $38.62 $293,329 - $419,104	10,852 Added 15.47%	80,990 $2.64 Million
Q4 2019 Jan 29, 2020	BUY	$32.92 - $37.36 $17,480 - $19,838	531 Added 0.76%	70,138 $2.75 Million
Q3 2019 Nov 07, 2019	BUY	$32.49 - $42.13 $260,439 - $337,714	8,016 Added 13.01%	69,607 $2.5 Million
Q2 2019 Jul 22, 2019	BUY	$36.98 - $41.52 $420,832 - $472,497	11,380 Added 22.66%	61,591 $2.67 Million
Q1 2019 Apr 17, 2019	BUY	$37.5 - $41.2 $429,150 - $471,492	11,444 Added 29.52%	50,211 $2.13 Million
Q4 2018 Feb 01, 2019	BUY	$38.47 - $43.86 $36,623 - $41,754	952 Added 2.52%	38,767 $1.69 Million
Q3 2018 Oct 25, 2018	BUY	$34.47 - $41.81 $148,738 - $180,410	4,315 Added 12.88%	37,815 $1.67 Million
Q2 2018 Aug 01, 2018	BUY	$32.98 - $35.16 $299,227 - $319,006	9,073 Added 37.14%	33,500 $1.22 Million
Q1 2018 May 03, 2018	BUY	$31.91 - $37.02 $141,265 - $163,887	4,427 Added 22.14%	24,427 $867,000
Q4 2017 May 07, 2018	BUY	$33.26 - $35.29 $198,761 - $210,893	5,976 Added 42.61%	20,000 $724,000
Q4 2017 Feb 05, 2018	BUY	$33.26 - $35.29 $1,995 - $2,117	60 Added 0.43%	14,024 $508,000
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $432,884 - $476,870	13,964	13,964 $499,000

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Exchange Capital Management, Inc. with notifications on news.

Account

Exchange Capital Management, Inc. Pfizer Inc Transaction History